Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 305

1.

Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes.

Vitale A, Cavalli G, Ruscitti P, Sota J, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cavallaro E, Massaro MG, Cipriani P, De Marchi G, De Vita S, Emmi G, Frassi M, Gerli R, Gremese E, Iannone F, Fornaro M, Paladini A, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Frediani B, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Grosso S, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Med (Lausanne). 2020 Feb 21;7:42. doi: 10.3389/fmed.2020.00042. eCollection 2020.

2.

NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium.

Manuel Sánchez-Maldonado J, Martínez-Bueno M, Canhão H, Ter Horst R, Muñoz-Peña S, Moñiz-Díez A, Rodríguez-Ramos A, Escudero A, Sorensen SB, Hetland ML, Ferrer MA, Glintborg B, Filipescu I, Pérez-Pampin E, Conesa-Zamora P, García A, den Broeder A, De Vita S, Hove Jacobsen SE, Collantes E, Quartuccio L, Netea MG, Li Y, Fonseca JE, Jurado M, López-Nevot MÁ, Coenen MJH, Andersen V, Cáliz R, Sainz J.

Sci Rep. 2020 Mar 9;10(1):4316. doi: 10.1038/s41598-020-61331-5.

3.

Verbal Fluency Test in Children with Neurodevelopmental Disorders.

Vaucheret Paz E, Puga C, Ekonen C, Pintos P, Lascombes I, De Vita S, Leist M, Corleto M, Basalo MJG.

J Neurosci Rural Pract. 2020 Jan;11(1):95-99. doi: 10.1055/s-0039-3400347. Epub 2020 Mar 3.

4.

Magma Degassing as a Source of Long-Term Seismicity at Volcanoes: The Ischia Island (Italy) Case.

Trasatti E, Acocella V, Di Vito MA, Del Gaudio C, Weber G, Aquino I, Caliro S, Chiodini G, de Vita S, Ricco C, Caricchi L.

Geophys Res Lett. 2019 Dec 28;46(24):14421-14429. doi: 10.1029/2019GL085371. Epub 2019 Dec 23.

5.

Rheumatoid factor-producing CD21low anergic clonal B-cells in essential mixed cryoglobulinaemia: a model for autoantigen-driven pathogenesis of infectious and non-infectious cryoglobulinaemias.

Del Padre M, Minafò YA, Marrapodi R, Radicchio G, Granata M, Camponeschi A, Fiorilli M, Quartuccio L, De Vita S, Casato M, Colantuono S, Visentini M.

Clin Exp Rheumatol. 2020 Jan 14. [Epub ahead of print]

PMID:
31969220
6.

Predicting lymphoma outcomes and risk factors in patients with primary Sjögren's Syndrome using gradient boosting tree ensembles.

Pezoulas VC, Exarchos TP, Tzioufas AG, De Vita S, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:2165-2168. doi: 10.1109/EMBC.2019.8857557.

PMID:
31946330
7.

Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions.

Idolazzi L, Zabotti A, Fassio A, Errichetti E, Benini C, Vantaggiato E, Rossini M, De Vita S, Viapiana O.

Clin Rheumatol. 2020 Jan 14. doi: 10.1007/s10067-020-04926-7. [Epub ahead of print]

PMID:
31938880
8.

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.

Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, Murgia S, Berti A, Silvestri E, Pazzola G, Bozzolo E, Leccese P, Raffeiner B, Parisi S, Leccese I, Cianci F, Bettio S, Sainaghi P, Ianniello A, Ravagnani V, Bellando Randone S, Faggioli P, Lomater C, Stobbione P, Ferro F, Colaci M, Alfieri G, Carubbi F, Erre GL, Giollo A, Franzolini N, Ditto MC, Balduzzi S, Padoan R, Bortolotti R, Bortoluzzi A, Cariddi A, Padula A, Di Scala G, Gremese E, Conti F, D'Angelo S, Matucci Cerinic M, Dagna L, Emmi G, Salvarani C, Paolazzi G, Roccatello D, Govoni M, Schiavon F, Caporali R, De Vita S; Italian Study Group on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study Group.

J Autoimmun. 2020 Mar;108:102397. doi: 10.1016/j.jaut.2019.102397. Epub 2020 Jan 9.

PMID:
31926833
9.

Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.

Brito-Zerón P, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, Kwok SK, Kvarnstrom M, Praprotnik S, Sene D, Gerli R, Solans R, Rischmueller M, Mandl T, Suzuki Y, Isenberg D, Valim V, Wiland P, Nordmark G, Fraile G, Bootsma H, Nakamura H, Giacomelli R, Devauchelle-Pensec V, Hofauer B, Bombardieri M, Trevisani VFM, Hammenfors D, Pasoto SG, Retamozo S, Gheita TA, Atzeni F, Morel J, Vollenweider C, Zeher M, Sivils K, Xu B, Bombardieri S, Sandhya P, De Vita S, Minniti A, Sánchez-Guerrero J, Kilic L, van der Heijden E, Park SH, Wahren-Herlenius M, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium.

Rheumatology (Oxford). 2019 Dec 24. pii: kez578. doi: 10.1093/rheumatology/kez578. [Epub ahead of print]

PMID:
31873754
10.

Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001-2017).

Valent F, Bond M, Cavallaro E, Treppo E, Rosalia Maria DR, Tullio A, Dejaco C, De Vita S, Quartuccio L.

Vasc Med. 2019 Dec 5:1358863X19886074. doi: 10.1177/1358863X19886074. [Epub ahead of print]

PMID:
31804152
11.

Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia.

Zabotti A, McGonagle DG, Giovannini I, Errichetti E, Zuliani F, Zanetti A, Tinazzi I, De Lucia O, Batticciotto A, Idolazzi L, Sakellariou G, Zandonella Callegher S, Sacco S, Quartuccio L, Iagnocco A, De Vita S.

RMD Open. 2019 Oct 23;5(2):e001067. doi: 10.1136/rmdopen-2019-001067. eCollection 2019.

12.

Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome.

Brito-Zerón P, Retamozo S, Kostov B, Baldini C, Bootsma H, De Vita S, Dörner T, Gottenberg JE, Kruize AA, Mandl T, Ng WF, Seror R, Tzioufas AG, Vitali C, Bowman S, Mariette X, Ramos-Casals M.

RMD Open. 2019 Oct 28;5(2):e001064. doi: 10.1136/rmdopen-2019-001064. eCollection 2019. Review.

13.

Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents.

Quartuccio L, Giovannini I, Pizzolitto S, Scarpa M, De Vita S.

Case Rep Rheumatol. 2019 Oct 13;2019:3410468. doi: 10.1155/2019/3410468. eCollection 2019.

14.

A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.

Gagno S, Poletto E, Bartoletti M, Quartuccio L, Romualdi C, Garziera M, Scalone S, Sorio R, Dreussi E, Zanusso C, De Mattia E, Roncato R, Cecchin E, Giorda G, De Vita S, Dal Bo M, Puglisi F, Toffoli G.

Gynecol Oncol. 2020 Jan;156(1):233-242. doi: 10.1016/j.ygyno.2019.10.019. Epub 2019 Nov 9.

PMID:
31711657
15.

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.

Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X; EULAR-Sjögren Syndrome Task Force Group.

Ann Rheum Dis. 2020 Jan;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114. Epub 2019 Oct 31.

PMID:
31672775
16.

Interplay of anti-SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren's syndrome.

Bartoloni E, Baldini C, De Vita S, Priori R, Giacomelli R, Bini V, Gerli R.

J Intern Med. 2020 Feb;287(2):214-215. doi: 10.1111/joim.12988. Epub 2019 Oct 31. No abstract available.

PMID:
31631415
17.

Dermoscopy in the differential diagnosis between malar rash of systemic lupus erythematosus and erythematotelangiectatic rosacea: an observational study.

Errichetti E, Lallas A, De Marchi G, Apalla Z, Zabotti A, De Vita S, Stinco G.

Lupus. 2019 Nov;28(13):1583-1588. doi: 10.1177/0961203319882493. Epub 2019 Oct 16.

PMID:
31619142
18.

Weight of salivary gland ultrasonography compared to other items of the 2016 ACR/EULAR classification criteria for Primary Sjögren's syndrome.

Jousse-Joulin S, Gatineau F, Baldini C, Baer A, Barone F, Bootsma H, Bowman S, Brito-Zerón P, Cornec D, Dorner T, de Vita S, Fisher B, Hammenfors D, Jonsson M, Mariette X, Milic V, Nakamura H, Ng WF, Nowak E, Ramos-Casals M, Rasmussen A, Seror R, Shiboski CH, Nakamura T, Vissink A, Saraux A, Devauchelle-Pensec V.

J Intern Med. 2020 Feb;287(2):180-188. doi: 10.1111/joim.12992. Epub 2019 Nov 12.

PMID:
31618794
19.

Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods.

De Vita S, Lauro G, Ruggiero D, Terracciano S, Riccio R, Bifulco G.

J Chem Inf Model. 2019 Nov 25;59(11):4678-4690. doi: 10.1021/acs.jcim.9b00428. Epub 2019 Nov 1.

PMID:
31593460
20.

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019.

21.

Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjögren's syndrome.

Gandolfo S, De Vita S.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):199-208. Epub 2019 Jul 22. Review.

22.

Current limitations and ongoing initiatives to evaluate the activity, damage and outcome of primary Sjögren's syndrome.

De Vita S, Zabotti A, Gandolfo S.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):24-26. Epub 2019 Aug 27. No abstract available.

23.

Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjögren's syndrome.

Gandolfo S, Bulfoni M, Fabro C, Russi S, Sansonno D, Di Loreto C, Cesselli D, De Vita S.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):55-64. Epub 2019 Aug 27.

24.

Sjögren's syndrome towards precision medicine: the challenge of harmonisation and integration of cohorts.

Goules AV, Exarchos TP, Pezoulas VC, Kourou KD, Venetsanopoulou AI, De Vita S, Fotiadis DI, Tzioufas AG.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):175-184. Epub 2019 Jul 3. Review.

25.

Hyperechoic bands detected by salivary gland ultrasonography are related to salivary impairment in established Sjögren's syndrome.

Zabotti A, Zandonella Callegher S, Gandolfo S, Valent F, Giovannini I, Cavallaro E, Lorenzon M, De Vita S.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):146-152. Epub 2019 Jul 22.

26.

Successful treatment of complicated pericarditis after myocardial infarction with interleukin-1 blocker.

De Vita S, De Biasio M, Zabotti A, Morocutti G, Quartuccio L, De Marchi G, Proclemer A.

Rheumatology (Oxford). 2020 Feb 1;59(2):445-447. doi: 10.1093/rheumatology/kez307. No abstract available.

PMID:
31359060
27.

Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.

Quartuccio L, Gandolfo S, Zabotti A, Zandonella Callegher S, Fabro C, De Vita S.

Front Immunol. 2019 Jul 10;10:1527. doi: 10.3389/fimmu.2019.01527. eCollection 2019.

28.

Predicting lymphoma development in patients with Sjögren's syndrome.

De Vita S, Gandolfo S.

Expert Rev Clin Immunol. 2019 Sep;15(9):929-938. doi: 10.1080/1744666X.2019.1649596. Epub 2019 Sep 12.

PMID:
31347413
29.

Radiomics-Based Assessment of Primary Sjögren's Syndrome From Salivary Gland Ultrasonography Images.

Vukicevic AM, Filipovic N, Milic V, Zabotti A, Hocevar A, De Lucia O, Filippou G, Frangi AF, Tzioufas A, De Vita S.

IEEE J Biomed Health Inform. 2020 Mar;24(3):835-843. doi: 10.1109/JBHI.2019.2923773. Epub 2019 Jul 18.

PMID:
31329136
30.

TREX1 variants in Sjogren's syndrome related lymphomagenesis.

Nezos A, Makri P, Gandolfo S, De Vita S, Voulgarelis M, Crow MK, Mavragani CP.

Cytokine. 2019 Jul 17:154781. doi: 10.1016/j.cyto.2019.154781. [Epub ahead of print]

PMID:
31326279
31.

Enhancing medical data quality through data curation: a case study in primary Sjögren's syndrome.

Pezoulas VC, Kourou KD, Kalatzis F, Exarchos TP, Venetsanopoulou AI, Zampeli E, Gandolfo S, Skopouli FN, De Vita S, Tzioufas AG, Fotiadis DI.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):90-96. Epub 2019 Jul 5.

32.

Emerging drugs for primary Sjögren's syndrome.

Gandolfo S, De Vita S.

Expert Opin Emerg Drugs. 2019 Jun;24(2):121-132. doi: 10.1080/14728214.2019.1634052.

PMID:
31286787
33.

Long-Lasting Anti-Inflammatory and Antinociceptive Effects of Acute Ammonium Glycyrrhizinate Administration: Pharmacological, Biochemical, and Docking Studies.

Maione F, Minosi P, Di Giannuario A, Raucci F, Chini MG, De Vita S, Bifulco G, Mascolo N, Pieretti S.

Molecules. 2019 Jul 4;24(13). pii: E2453. doi: 10.3390/molecules24132453.

34.

Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome.

Galli M, Monti G, Marson P, Scaini P, Pietrogrande M, Candela M, Castelnovo L, Faggioli P, Novati P, Zani R, Mascia MT, Saccardo F, Mazzaro C, Sarzi-Puttini P, Sebastiani M, Quartuccio L, De Vita S.

Autoimmun Rev. 2019 Aug;18(8):778-785. doi: 10.1016/j.autrev.2019.06.008. Epub 2019 Jun 8.

PMID:
31181326
35.

Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study.

Bartoloni E, Bistoni O, Alunno A, Cavagna L, Nalotto L, Baldini C, Priori R, Fischetti C, Fredi M, Quartuccio L, Carubbi F, Montecucco C, Doria A, Mosca M, Valesini G, Franceschini F, De Vita S, Giacomelli R, Mirabelli G, Bini V, Gabrielli A, Catassi C, Gerli R.

J Clin Med. 2019 Apr 19;8(4). pii: E540. doi: 10.3390/jcm8040540.

36.

Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.

Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. eCollection 2019.

37.

Salivary gland ultrasonography in primary Sjögren's syndrome: opportunities and challenges.

Devauchelle-Pensec V, Zabotti A, Carvajal-Alegria G, Filipovic N, Jousse-Joulin S, De Vita S.

Rheumatology (Oxford). 2019 Mar 19. pii: kez079. doi: 10.1093/rheumatology/kez079. [Epub ahead of print]

PMID:
30892624
38.

Medical data quality assessment: On the development of an automated framework for medical data curation.

Pezoulas VC, Kourou KD, Kalatzis F, Exarchos TP, Venetsanopoulou A, Zampeli E, Gandolfo S, Skopouli F, De Vita S, Tzioufas AG, Fotiadis DI.

Comput Biol Med. 2019 Apr;107:270-283. doi: 10.1016/j.compbiomed.2019.03.001. Epub 2019 Mar 7.

PMID:
30878889
39.

Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study.

Macchioni P, Salvarani C, Possemato N, Gutierrez M, Grassi W, Gasparini S, Perricone C, Perrotta FM, Grembiale RD, Bruno C, Tripolino C, Govoni M, Ciancio G, Farina I, Ramonda R, Frallonardo P, Desiati F, Scarpa R, Costa L, Zabotti A, De Vita S, D'Attino RM, Gualberti G, Merolla R, di Luzio Paparatti U, Aldigeri R, Marchesoni A.

J Rheumatol. 2019 Aug;46(8):904-911. doi: 10.3899/jrheum.171411. Epub 2019 Mar 15.

40.

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.

Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

41.

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Canet LM, Sánchez-Maldonado JM, Cáliz R, Rodríguez-Ramos A, Lupiañez CB, Canhão H, Martínez-Bueno M, Escudero A, Segura-Catena J, Sorensen SB, Hetland ML, Soto-Pino MJ, Ferrer MA, García A, Glintborg B, Filipescu I, Pérez-Pampin E, González-Utrilla A, Nevot MÁL, Conesa-Zamora P, den Broeder A, De Vita S, Jacobsen SEH, Collantes-Estevez E, Quartuccio L, Canzian F, Fonseca JE, Coenen MJH, Andersen V, Sainz J.

Pharmacogenomics J. 2019 Dec;19(6):582. doi: 10.1038/s41397-019-0084-2.

PMID:
30760878
42.

The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions.

Idolazzi L, Zabotti A, Fassio A, Errichetti E, Benini C, Vantaggiato E, Rossini M, De Vita S, Viapiana O.

Clin Rheumatol. 2019 Mar;38(3):913-920. doi: 10.1007/s10067-019-04437-0. Epub 2019 Jan 15. Erratum in: Clin Rheumatol. 2020 Jan 14;:.

PMID:
30645755
43.

Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement.

Zuliani F, Zabotti A, Errichetti E, Tinazzi I, Zanetti A, Carrara G, Quartuccio L, Sacco S, Giovannini I, Stinco G, De Vita S.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):593-599. Epub 2018 Dec 19.

44.

Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data.

Quartuccio L, Zabotti A, Del Zotto S, Zanier L, De Vita S, Valent F.

J Adv Res. 2018 Sep 19;15:87-93. doi: 10.1016/j.jare.2018.09.003. eCollection 2019 Jan.

45.

Towards the Establishment of a Biomedical Ontology for the Primary Sjögren's Syndrome.

Pezoulas VC, Exarchos TP, Andronikou V, Varvarigou T, Tzioufas AG, De Vita S, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:4089-4092. doi: 10.1109/EMBC.2018.8513349.

PMID:
30441255
46.

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2019 Jan;18(1):93-106. doi: 10.1016/j.autrev.2018.08.003. Epub 2018 Nov 5. Review.

PMID:
30408582
47.

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy.

De Mattia E, Dreussi E, Montico M, Gagno S, Zanusso C, Quartuccio L, De Vita S, Guardascione M, Buonadonna A, D'Andrea M, Pella N, Favaretto A, Mini E, Nobili S, Romanato L, Cecchin E, Toffoli G.

Front Pharmacol. 2018 Oct 4;9:1101. doi: 10.3389/fphar.2018.01101. eCollection 2018.

48.

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Canet LM, Sánchez-Maldonado JM, Cáliz R, Rodríguez-Ramos A, Lupiañez CB, Canhão H, Martínez-Bueno M, Escudero A, Segura-Catena J, Sorensen SB, Hetland ML, Soto-Pino MJ, Ferrer MA, García A, Glintborg B, Filipescu I, Pérez-Pampin E, González-Utrilla A, Nevot MÁL, Conesa-Zamora P, Broeder AD, De Vita S, Jacobsen SEH, Collantes-Estevez E, Quartuccio L, Canzian F, Fonseca JE, Coenen MJH, Andersen V, Sainz J.

Pharmacogenomics J. 2019 Feb;19(1):83-96. doi: 10.1038/s41397-018-0057-x. Epub 2018 Oct 5. Erratum in: Pharmacogenomics J. 2019 Feb 14;:.

PMID:
30287909
49.

The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.

De Vita S, Gandolfo S, Zandonella Callegher S, Zabotti A, Quartuccio L.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):150-156. Epub 2018 Aug 14.

50.

Imaging in primary Sjögren's syndrome: the 'obsolete and the new'.

Baldini C, Zabotti A, Filipovic N, Vukicevic A, Luciano N, Ferro F, Lorenzon M, De Vita S.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):215-221. Epub 2018 Aug 14. Review.

Supplemental Content

Loading ...
Support Center